Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.73 |
| ▸ | IDO1 | P14902 | 1/20 | 0.61 |
| ▸ | NAMPT | P43490 | 2/20 | 0.56 |
| ▸ | GPR183 | P32249 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | KLK7 | P49862 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.49 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20838672 | 1.00 | EPHX2 (0.73) | EPHX2IDO1NAMPTGPR183L3MBTL1 | |
| SCHEMBL17737051 | 1.00 | EPHX2 (0.73) | EPHX2IDO1NAMPTGPR183L3MBTL1 | |
| SCHEMBL17730049 | 0.94 | IDO1 (0.72) | EPHX2IDO1NAMPTGPR183L3MBTL1 | |
| SCHEMBL20838628 | 0.94 | EPHX2 (0.65) | EPHX2IDO1NAMPTGPR183L3MBTL1 | |
| SCHEMBL17729993 | 0.94 | IDO1 (0.72) | EPHX2IDO1NAMPTGPR183L3MBTL1 | |
| SCHEMBL17737052 | 0.94 | EPHX2 (0.65) | EPHX2IDO1NAMPTGPR183L3MBTL1 | |
| SCHEMBL17737285 | 0.94 | EPHX2 (0.65) | EPHX2IDO1NAMPTGPR183L3MBTL1 | |
| SCHEMBL17729994 | 0.94 | IDO1 (0.72) | EPHX2IDO1NAMPTGPR183L3MBTL1 | |
| SCHEMBL17318325 | 0.94 | IDO1 (0.71) | EPHX2IDO1NAMPTGPR183L3MBTL1 | |
| SCHEMBL17730903 | 0.94 | IDO1 (0.71) | EPHX2IDO1NAMPTGPR183L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11242319-B2 | Immunoregulatory agents | FLEXUS BIOSCIENCES, INC. (US) | 2022-02-08 | — | — | US | disclosed |
| US-20190092729-A1 | IMMUNOREGULATORY AGENTS | FLEXUS BIOSCIENCES, INC. | 2019-03-28 | — | — | US | disclosed |
| WO-2016073738-A2 | IMMUNOREGULATORY AGENTS | FLEXUS BIOSCIENCES, INC. (US) | 2016-05-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11242319-B2 | Immunoregulatory agents | IDO1, IDO2, INMT | EPHX2 611/4885IDO1 1/4885NAMPT 457/4885 |
| US-20190092729-A1 | IMMUNOREGULATORY AGENTS | IDO1, IDO2, INMT | EPHX2 611/4885IDO1 1/4885NAMPT 457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.